Transcript
The cost of living is skyrocketing across Canada and the health of Canadians is feeling the impact.
According to the Canadian Cancer Society, nearly a quarter of Canadians in 2024 reported splitting pills, skipping doses or not refilling a prescription due to cost.
They report that 28 per cent of Canadians have had to dig into their grocery or housing budgets to afford their medications.
Not following the instructions that accompany prescriptions can lead to increased hospitalizations, especially for chronic conditions that require careful management.
Attempting to address the issue, NDP leader Jagmeet Singh has been pushing a new pharmacare act, Bill C-64.
Not everyone is happy with the proposal though. Facing opposition from some government members and provinces, the future of the act is uncertain.
The goals of the act are: Improving the accessibility and affordability of prescription drugs and related products, the appropriate use of such drugs and products, the development of a national formulary of essential prescription drugs and related products, and establishing a national bulk purchasing strategy.
Bill C-64 hopes to eventually cover all necessary medications and devices. But to start, it’ll cover the cost of some contraception and diabetes medications and devices.
Estimating it will help 13 million Canadians, the pharmacare act is trying to remove the main barrier to access: cost.
An admirable goal, it’ll take a lot of preparation and planning before it can be implemented.
The act states that if approved, the Minister of Health, Mark Holland, must create a committee of experts to make recommendations on the implementation of a national, universal, single-payer pharmacare program within 30 days.
He will also have to work with the Canadian Drug Agency who will determine which drugs and devices should be covered under the act, weigh in on purchasing strategies, and define appropriate use of prescription drugs that can be applied around the country.
But executing the plan across Canada might never happen. Alberta and Quebec have already made it known they’d like to opt out of the act and want to invest the money into their own drug plans instead.
Many other provinces are on the fence, waiting for more information before committing either way.
Implementing this act would eventually replace public and private health insurance plans.
Instead, there would be a $5 copayment for name brand drugs. Some populations, like Indigenous Peoples, would be exempt from this cost.
As of now, Pharmacare Act, Bill C-64 is still in the early stages. It has not been approved and there is no timeline for implementation or accomplishing the goals it sets out.
Subscribe to The Health Insider for updates on the proposed Pharmacare Act and on other issues that impact the state of Canadian healthcare.
Sources:
~ Read more from The Health Insider ~
- Why Your Local Pharmacist is the Primary Care Partner You’ve Been Overlooking
Learn how new 2025 healthcare updates allow Canadian pharmacists to manage your prescriptions and vaccines, often with no appointment needed. - Aging at Home: The 2026 Canadian Senior Independence Guide90% of Canadians want to age at home. Discover the 2026 guide to maintain your independence and dignity.
- Health Canada Authorizes Nemluvio® for Eczema and Prurigo NodularisHealth Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
- Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke RiskHealth Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
- Confronting the Silence Around Dementia: Why Not Knowing Isn’t a StrategyNew data reveals Canadians are avoiding dementia diagnoses and how facing the facts early can preserve your independence and health.
- The Mood Menu: How Your Plate Shapes Your MindDiscover how simple food choices like turkey and yogurt can boost your serotonin and stabilize your mood.
The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.
